Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Treasury Shares (2023 - 2024)

Mangoceuticals (MGRX) has disclosed Treasury Shares for 2 consecutive years, with $1.4 million as the latest value for Q1 2024.

  • Quarterly Treasury Shares rose 10.8% to $1.4 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Mar 2024, up 10.8% year-over-year, with the annual reading at $1.3 million for FY2023, N/A changed from the prior year.
  • Treasury Shares hit $1.4 million in Q1 2024 for Mangoceuticals, up from $1.3 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.4 million in Q1 2024 to a low of $70866.0 in Q3 2023.